2012年10月5日 星期五

目錄

  1. The role of allergy in Meniere's disease.
  2. Allergic and immunologic aspects of Meniere's disease.
  3. Allergic management of Meniere's disease: an outcome study.
  4. Provocation of endolymphatic hydrops with a prick test in Meniere's disease.
  5. Allergic and immunologic features of Ménière's disease.
  6. Etiology, pathophysiology of symptoms, and pathogenesis of Meniere's disease.
  7. Ménière's syndrome and allergy.
  8. Endolymphatic hydrops in asymptomatic ears in unilateral Ménière's disease.
  9. Inhalant allergy and Meniere's disease: Use of electrocochleography and intranasal allergen challenge as investigational tools.
  10. Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops?
  11. Meniere's disease: evidence of an immune process.
  12. Allergy and Ménière's disease.
  13. A subpopulation of Menière's patients produce antibodies that bind to endolymphatic sac antigens.
  14. Immuno-pathogenesis in Meniere's disease.
  15. Allergy and its relation to Meniere's disease.
  16. Meniere's disease and endolymphatic hydrops without Meniere's symptoms: temporal bone histopathology.
  17. Perilymphatic fistula and Meniere's disease. Clinical series and literature review.
  18. Use of electrocochleography for assessing endolymphatic hydrops in patients with Lyme disease and Ménière's disease.
  19. Demonstration of autoantibodies to the endolymphatic sac in Meniere's disease.
  20. Use of electrocochleography to monitor antigenic challenge in Menière's disease.
  21. Pathogenesis of Menière's disease.
  22. Meniere's attacks occur in the inner ear with excessive vasopressin type-2 receptors.
  23. ence of autoantibodies in the sera of Meniere's disease.
  24. History of Meniere's disease and its clinical presentation.
  25. Summating potential and action potential ratio in Meniere's disease before and after treatment.
  26. Brain and inner-ear fluid homeostasis, cochleovestibular-type tinnitus, and secondary endolymphatic hydrops.
  27. Autoimmune reactivity in Ménière's disease: a preliminary report.
  28. Antibodies of type II collagen and immune complexes in Menière's disease.
  29. Immunological pathogenesis of endolymphatic hydrops and its relation to Menière's disease.
  30. A diagnostic test for Ménière's Disease and Cochlear Hydrops: impaired high-pass noise masking of auditory brainstem responses.
  31. Imaging of Meniere's disease.
  32. Local overpressure treatment reduces vestibular symptoms in patients with Meniere's disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study.
  33. Cochlear implantation in patients with bilateral Ménière's syndrome.
  34. Evaluation of the effect of streptomycin perfusion of the labyrinth in the treatment of Meniere's disease and endolymphatic hydrops.
  35. Plain radiological findings in Ménière's disease.
  36. The importance of IgG auto-antibodies, anti- collagen type II specific in Menière's disease and progressive hearing loss.
  37. Allergy in Ménière's disease related fluctuating hearing loss preliminary findings in a double-blind crossover clinical study.
  38. Serum antibodies against heat shock protein 70 in Menière's disease.
  39. Diagnosis of cochlear Ménière's disease with electrocochleography.
  40. Etiology and treatment of fluid retention (hydrops) in Ménière's syndrome.
  41. Immunoperoxidase study of the endolymphatic sac in Menière's disease.
  42. Meniere's disease: prevalence of contralateral ear involvement.
  43. Sensory cell damage in two-phase endolymphatic hydrops: a morphologic evaluation of a new experimental model by low-voltage scanning techniques.
  44. Serum antibodies to type II collagen and immune complex in cases of Menière's disease.
  45. Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.
  46. Endolymphatic sac enhancement surgery in elderly patients with Ménière's disease.
  47. Immunological responses in acute low-tone sensorineural hearing loss and Ménière's disease.
  48. Ménière's disease.
  49. Aldosterone assessment in patients with Menière's disease.
  50. Meniere's disease: overview, epidemiology, and natural history.
  51. Visualization of endolymphatic hydrops in patients with Meniere's disease.
  52. Results of labyrinthectomy in the treatment of Menière's disease and delayed endolymphatic hydrops.
  53. Immune mechanisms in Meniere's syndrome.
  54. HSP70 antibodies in 80 patients with "clinically certain" Meniere's disease.
  55. The basic science of Meniere's disease and endolymphatic hydrops.
  56. In reference to visualization of endolymphatic hydrops in patients with Meniere's disease.
  57. Immunoglobulin E and circulating immune complexes in endolymphatic hydrops.
  58. Low-dose oral methotrexate management of patients with bilateral Ménière's disease.
  59. Alternobaric oxygen therapy in long-term treatment of Ménière's disease.
  60. Effects of endolymphatic sac drainage with steroids for intractable Meniere's disease: a long-term follow-up and randomized controlled study.
  61. Angioneurosis in Menière's disease.
  62. Menière's disease: an immune complex-mediated illness?
  63. Immune-mediated sensorineural hearing loss.
  64. Plasma vasopressin and V2 receptor in the endolymphatic sac in patients with delayed endolymphatic hydrops.
  65. The exacerbation of symptoms in Menière's disease during the premenstrual period.
  66. Vestibular type of Mondini anomalies with BPPV and Meniere's disease-like symptoms.
  67. Delayed endolymphatic hydrops.
  68. Antidiuretic hormone (ADH) and endolymphatic hydrops.
  69. Immunological aspects of Menière's disease.
  70. Depersonalization, vertigo and Ménière's disease.
  71. Prevalence of allergy in Meniere's disease.
  72. Contemporary perspectives on the pathophysiology of Meniere's disease: implications for treatment.
  73. Meniere's disease and allergy: allergens and cytokines.
  74. Electrocochleographic changes after intranasal allergen challenge: A possible diagnostic tool in patients with Meniere's disease.
  75. Detection of antibody to sialyl-i, a possible antigen in patients with Meniere's disease.
  76. Three-dimensional Fourier transformation constructive interference in steady state magnetic resonance imaging of the inner ear in patients with unilateral and bilateral Menière's disease.
  77. Prevalence of heat shock protein in patients with Meniere's disease and allergy.
  78. The syndrome of physical or intrinsic allergy of the head; vasomotor rhinitis and the vasodilating pain syndrome, their relationship to myalgia and endolymphatic hydrops (Ménière's disease) and the reasons for including all four as the syndrome of physical allergy of the head.
  79. Obstructing lesions of the endolymphatic sac and duct mimicking Ménière's disease.
  80. Antibodies to inner ear antigens in Meniere's disease.
  81. Stress and symptoms of Menière's disease: a time- series analysis.
  82. Ménière's disease review 2005.
  83. Evaluating quality of life after endolymphatic sac surgery: The Ménière's Disease Outcomes Questionnaire.
  84. Effects of middle ear pressure changes on clinical symptoms in patients with Ménière's disease--a clinical multicentre placebo-controlled study.
  85. Surgical observations on the endolymphatic sac in Meniere's disease.
  86. Transtympanic gentamicin perfusion for the treatment of Meniere's disease.
  87. Meniere's disease: the incidence of hydrops in the contralateral asymptomatic ear.
  88. Psychological characteristics of patients with Ménière's disease compared with patients with vertigo, tinnitus, or hearing loss.
  89. Post-traumatic hydrops.
  90. The clinical study of immune factors relative to Menière's disease.
  91. The cervicogenic otoocular syndrome: a suspected forerunner of Ménière's disease.
  92. Meniere's disease.
  93. Immunologic and serologic testing in patients with Ménière's disease.
  94. Proto-oncogene Raf-1 as an autoantigen in Meniere's disease.
  95. Allergy and Meniere's disease: a review.
  96. The discovery of the pathogenesis of Menière's disease.
  97. Provocation of nystagmus and deviation by type I allergy in the inner ear of the guinea pig.
  98. Hypothesis: could Meniere's disease be a channelopathy?
  99. Anti-heat shock protein 70 antibodies in Meniere's disease.
  100. Hypofibrinolysis in Menière's disease. Preliminary report.
  101. Combined vestibular neurectomy and endolymphatic sac shunt via the retrosigmoid approach in the treatment of Ménière's disease.
  102. Distribution and density of subepithelial collagen in the endolymphatic sac in patients with Meniere's disease.
  103. Menière's disease and autoimmunity: clinical study and survey.
  104. On pathogenesis of symptoms in Ménière's disease.
  105. Patients' subjective evaluations of quality of life related to disease-specific symptoms, sense of coherence, and treatment in Ménière's disease.
  106. Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Ménière's disease.
  107. Benign paroxysmal positional vertigo in patients with Ménière's disease treated with intratympanic gentamycin.
  108. Aquaporins and Meniere's disease.
  109. HLA antigens in the pathogenesis of Menière's disease.
  110. Endolymphatic sac-vein decompression for intractable Meniere's disease: long term treatment results.
  111. Postural control and glycerol test in Ménière's disease.
  112. Menière's disease: evolution of a definition.
  113. The role of allergy in fluctuating hearing loss.
  114. Allergy for the otologist. External canal to inner ear.
  115. Is recurrent loss of low frequency tone perception --without vertigo--a precursor of Meniere disease?.
  116. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
  117. Diagnosis of Meniere's disease: routine and extended tests.
  118. Perilymphatic and endolymphatic pressure in the guinea pig after distal dissection of the endolymphatic sac.
  119. Vestibular nerve section in a child with intractable Menière's disease.
  120. Electrocochleography in patients with Meniere's disease.
  121. Use of a screening RAST in a large neuro-otologic practice.
  122. Endolymphatic mastoid shunt versus endolymphatic sac decompression for Ménière's disease.
  123. External aperture of the vestibular aqueduct in Meniere's disease.
  124. Serum antidiuretic hormone levels in patients with unilateral Meniere's disease.
  125. Immunologic abnormality in Menière's disease.
  126. Diameter of the cochlear nerve in endolymphatic hydrops: implications for the etiology of hearing loss in Ménière's disease.
  127. Histopathologic changes of contralateral human temporal bone in unilateral Ménière's disease.
  128. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
  129. Electrocochleography in the diagnosis of Meniere's disease.
  130. Medical management of Meniere's disease.
  131. Co-morbidity of migraine and Ménière's disease -- is allergy the link?
  132. Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease?
  133. Relationship of the cochlear aqueduct and inner ear pressure in Ménière's disease and in a normal population.
  134. Aquaporins as potential drug targets for Meniere's disease and its related diseases.
  135. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
  136. An update on the surgical treatment of Ménière's diseases.
  137. Ménière's disease.
  138. Definition, classification and reporting of Menière's disease and its symptoms.
  139. Electrocochleography and gentamicin therapy for Ménière's disease: a preliminary report.
  140. Clinical characteristics of tinnitus in Ménière's disease.
  141. Etiopathogenesis of Meniere's disease: a hypothesis.
  142. Natural history of Menière's disease: staging the patients or their symptoms?
  143. Circulating auto-antibodies in Ménière's disease.
  144. The classification and treatment of Menière's disease.
  145. Meniere's disease study: three-year progress report.
  146. The inter-relationship of vertigo and stress.
  147. Type II collagen autoimmunity in otosclerosis and Meniere's Disease.
  148. Ménière's disease as a form of cranial polyganglionitis.
  149. The choice of the method for treating patients with Menière's disease and similar diseases.
  150. Allergic factors in Meniere's disease.
  151. Menière's disease: etiology and natural history.
  152. Antigenic excitation in Meniere's disease.
  153. Meniere's disease and allergy, with special reference to immunoglobulin E and IgE antibody (reagin) in serum.
  154. Type II collagen autoimmunity and Ménière's disease.
  155. Immune status in patients with Menière's disease.
  156. Meniere's disease: update of etiopathogenetic theories and proposal of a possible model of explanation.
  157. Evidence of persistent viral infection in Menière's disease.
  158. Hyperlipoproteinemia, hyperinsulinism, and Meniere's disease.
  159. Contribution to the therapy of Menière's disease (author's transl).
  160. Ménière's disease.
  161. Allergic backgrounds of Meniere's disease.
  162. The significance of the human endolymphatic sac and its possible role in Menière's disease.
  163. Value of immunobiological tests in Menière's disease and in rapidly progressive sensorineural deafness.
  164. Vertigo and autoimmunity.
  165. Pathophysiology of Menière's disease.
  166. Ménière's disease; endolymphatic hydrops.
  167. Allergic management of Meniere disease.
  168. Molecular and cellular pathology of Meniere's disease.
  169. Symposium: management of Ménière's disease. 3. Medical management of endolymphatic hydrops.
  170. Some remarks on the patient suffering from Méniére's disease.
  171. Meniere's disease might be an autoimmune condition?
  172. Pathophysiologic theories in the etiology of Meniere's disease.
  173. A preliminary study on the mechanism of immune injury of Menière's disease--type V collagen play the role of antigen.
  174. Allergy in relation to Meniere's syndrome, labyrinthitis, and headache.
  175. Menière's disease: allergy, immunology, psychosomatic, hypo- and hypertonus.
  176. Staging Meniere's disease (or any inner ear dysfunction) and the use of the vertigogram.
  177. Diagnosis and treatment of endolymphatic hydrops (Ménière's disease).
  178. Ablation of luteal phase symptoms of Menière's disease with leuprolide.
  179. Advance study in the etiology of Menière's disease.
  180. The management of tinnitus with or without Menière's disease.
  181. Relationship between immune complex and total hemolytic complement in endolymphatic hydrops.
  182. Garlic food allergy with symptoms of Ménière's disease.
  183. No increased serum levels of antifood antibodies in patients with Ménière's disease.
  184. The characteristics and natural history of tinnitus in Meniere's disease.
  185. Psychosomatic aspects of Menière's disease.
  186. Autoimmune Menière's disease: current concept.
  187. Menière's disease and tinnitus.
  188. Allergic therapy for Meniere's disease.
  189. Ménière's attacks associated with facial paralysis.
  190. Essay on the pathogenesis of Meniere's vertigo.
  191. The value of nausea and vomiting due to Ménière's disease--a theory.
  192. The natural history of the vertigo component of Meniere's disease.
  193. Hydrops of labyrinth (Ménière's disease); diagnosis; results of labyrinth surgery.
  194. Ménière's disease and plasmatic hyperosmolarity.
  195. Allergic basis of Menière's disease.
  196. Dynamics of various blood electrolytes in patients with Menière's disease after desiccation.
  197. Pros and cons in the allergic theory of Meniere's disease.
  198. Menière's disease. Etiology, natural history, and results of treatment.
  199. The diagnosis and evaluation of allergic disorders with food intolerance in Meniere's disease.
  200. Medical treatment of Menière disease (author's transl).
  201. Terminal otosclerosis with the appearance of Menière's disease.
  202. The allergic reactivity of the body in Meniere's disease.
  203. Association of gastro-duodenal lesions with Ménière's syndrome.
  204. Immunohistochemistry of the Scarpa's ganglion and the crista ampullaris of patients with Menière disease.
  205. Predominance of left ear in Meniére's disease, sudden deafness, inner ear damage, tinnitus and abnormally patent eustachian tube.
  206. [Trigeminal paralysis in Meniere's disease].
  207. Fungal derivatives as antigenic excitants of episodic vertigo.
  208. [Pharmaco-pupillometry with methacholine in Ménière's disease].
  209. Do musical hallucinations always arise from the inner ear?
  210. [Changes in tubal permeability and Ménière's disease].
  211. [Effectiveness of sodium bicarbonate (CO3 NaH) therapy of symptoms of Menière's disease, especially vertigo].
  212. [Etiopathogenesis and diagnosis of Ménière's disease].
  213. Vertigo and Ménière's syndrome.
  214. [Diseases associated with Ménière's disease].
  215. [The behavior of arterial pressure in patients with Ménière's disease].
  216. The role of food allergy in otolaryngology disorders.
  217. Benzyl cinnamate in treatment of Ménière's syndrome and tinnitus aurum; a clinical report.
  218. The role of labyrinthectomy and cochlear implantation in Menière's disease.
  219. The possible roles of hormones and enzymes in the production of the acute attack in Menière's disease.
  220. [Otoneurologic problems in the course of Ménière's disease. I].
  221. Headache and Menière's disease.
  222. Allergy and the refractory otorhinolaryngology patient.
  223. [Nursing of patients with vertigo--with special reference to Menière's disease].
  224. Symposium: management of Ménière's disease. I. Historical aspects of Ménière's disease (Prosper Ménière).
  225. [Meniere's disease and otospongiosis].
  226. [Treatment of Menière's disease].
  227. [Resection of the tympanic plexus for Meniere's disease and cervical osteochondrosis].
  228. Is allergy related to Meniere's disease?
  229. [A rare case of simultaneous development of Meniere's disease and glaucoma].
  230. Meniere's disease. The inner ear out of balance.
  231. Hypoglycemia in Meniere's disease.
  232. [Status of the central nervous system in Ménière's syndrome].
  233. [Case of traumatic Menière's syndrome with vertical vertigo].
  234. Endolymphatic ion concentration in Meniere's disease.
  235. Ménière's syndrome.
  236. Ménière disease.
  237. [Discussion of the paper of Mr. J. van den Branden presented at the meeting of September 26, 1953 entitled: "Menière's vertigo"].
  238. [Circulatory disorders in Ménière's disease].
  239. Clinical evaluation of antivert in symptoms associated with Ménière's syndrome.
  240. Surgical management of vertigo of peripheral origin due to Meniere's disease and other causes.
  241. [Allergy and the inner ear].
  242. Biochemical studies of inner ear fluid in man. Changes in otosclerosis, Meniere's disease, and acoustic neuroma.
  243. The dizzy patient--allergic aspect.
  244. Evidence for a Vascular Mechanism in Ménière's Syndrome.
  245. "How I do it" - otology and neurotology. A specific issue and its solution. Etiology as a guide in the management of Menière's disease.
  246. Ménière's disease.-WRIGHT AJ.
  247. Ménière's disease.-HALLPIKE CS.
  248. Meniere's disease.-NELSON-JONES A.
  249. Ménière's disease.-HARRISON ME.
  250. Ménière's disease.-CAWTHORNE T.
  251. Ménière's Disease-A Critical Review.
  252. [Etiology and classification of Ménière's disease].
  253. A fresh clinical look at Meniere's disease.
  254. Menière's syndrome.
  255. Ménière's syndrome; the basic fault?
  256. Ménière's, a synonym of confusion.
  257. [A BIBLIOGRAPHY OF FOREIGN LITERATURE TO THE PRESENT DAY ON MENIERE'S DISEASE].
  258. Ménière's disease.-LINDSAY JR.
  259. [Central processes in Meniere's syndromes].
  260. Meniere's disease. Recent advances in basic and clinical aspects. Proceedings of the Satellite Bárány Society Meeting. Taipei, May 22-23, 1990.
  261. Immunoglobulin E and circulating immune complexes in endolymphatic hydrops.
  262. Symposium on Meniere's disease.
  263. Meniere's disease diagnosis and treatment.
  264. Meniere's disease.
  265. Ménière's disease; a personal experience.
  266. [Meniere's disease--new discoveries and posibilities].
  267. [Menière's disease].-Jongkees LB.
  268. [Menière's disease].-Levshova AS.
  269. The history of Meniere's disease.
  270. Letters to the editor: diagnosis of Ménière's disease.
  271. [Vértigo].
  272. The possible roles of hormones and enzymes in the production of the acute attack in Menière's disease.
  273. Allergy in otolaryngology.
  274. Letter: Endolymphatic hydrops and glaucoma production.
  275. [Ménière's disease].
  276. [Ménière's syndrome].
  277. [Meniere's disease].
  278. A note on Menière's syndrome.
  279. [Menière's disease].-Kalinovskaia IIa.
  280. [Meniere's disease].-Kawada M.
  281. Ménière's disease.-Fuller AP.
  282. [Ménière's disease].-Waar CA.
  283. [Ménière's syndrome].
  284. [Experimental reproduction in the cat of "Meniere's" labyrinthosis with chronic evolution].
  285. [Meniere's disease: with special reference to recent activities in the Otorhinolaryngology Department at Osaka University].
  286. The allergy--part 1.
  287. Remarks on Vertigo, and the Group of Symptoms Sometimes Called Menière's Disease.
  288. [Menier's disease. Recent acquisitions].
  289. Clinical allergy--state of the art.
  290. Value of histamine skin tests in Ménière's disease.
  291. [Introduction to course in allergy and allergy diagnosis].
  292. Labyrinthine Vertigo (Ménière's Symptoms-Non- infective) treated by Operation.
  293. Labyrinthine Vertigo (Menière's Symptoms-Non- infective) treated by Operation.
  294. Prismatic effect on symptoms of Menière's disease.
  295. [On the role of allergy in inflammatory rheumatism and its treatment with streptococcal vaccine via arterial route].
  296. [Immunopathologic aspects of recurrent phlebitis and nodular vascularitis. Therapeutic applications].
  297. A Case of Acute Ménière's Symptoms in Splenomedullary Leucocythæmia, with Special Reference to the Anatomical Changes found in Acute Leucocythæmic Affections of the Ear: Including a Pathological Report on the Present Case.
  298. Nutritional deficiencies: their role in allergy and intolerance.
  299. Allergy-immunology. Unproved techniques and theories.
  300. Clinical allergy.-Owen RM.
  301. Letter: Controversial techniques in allergy.
  302. Allergy and otolaryngology.
  303. [Role of allergy in the pathogenesis of adhesion disease].
  304. Gastro-intestinal Sepsis, a Cause of Ménière's Symptoms.
  305. Case with Well-defined and Transitory Ménière's Symptoms; (?) Migraine with Auditory and Vistibular Phenomena.
  306. ABLATION OF THE LABYRINTH IN A CASE WITH MENIERE'S SYMPTOMS.
  307. GASTRO-INTESTINAL SEPSIS A CAUSE OF MENIERE'S SYMPTOMS.
  308. Does allergy protect against cancer?
  309. [Psychosomatic approach to allergies].
  310. [The nurse and allergy].
  311. Diagnosing allergies.
  312. The relation of cancer to allergy.
  313. [Immunologic aspect of microbial allergy].
  314. [Allergies].
  315. Role of allergy in clinical medicine. II.

沒有留言:

張貼留言